Evidence map›Paper›PMID 35212363›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Delayed mortality among solid organ transplant recipients hospitalized for COVID-19.

Madeleine R Heldman, Olivia S Kates, Kassem Safa, Camille N Kotton, Ashrit Multani, Sarah J Georgia, Julie M Steinbrink, Barbara D Alexander, Emily A Blumberg, Brandy Haydel and 31 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 18 institutions in 2 countries.

Madeleine R HeldmanDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Olivia S KatesDivision of Infectious Diseases, Johns Hopkins University, Baltimore, MD, USA.
Kassem SafaMassachusetts General Hospital, Boston, MA, USA.
Camille N KottonMassachusetts General Hospital, Boston, MA, USA.
Ashrit MultaniDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID 0000-0003-4043-4287
Sarah J GeorgiaMassachusetts General Hospital, Boston, MA, USA.
Julie M SteinbrinkDivision of Infectious Diseases, Duke University, Durham, NC, USA.
Barbara D AlexanderDivision of Infectious Diseases, Duke University, Durham, NC, USA.
Emily A BlumbergDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Brandy HaydelRecanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Vagish HemmigeDivision of Infectious Disease, Albert Einstein College of Medicine / Montefiore Medical Center, Bronx, NY, USA.
Marion Hemmersbach-MillerSection of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA.
Ricardo M La HozDivision of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Lisset MoniUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Yesabeli CondorUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Sandra FloresUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Carlos G MunozUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Juan GuitierrezUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Esther I DiazUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Daniela DiazUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Rodrigo ViannaUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Giselle GuerraUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Matthias LoebeUniversity of Miami/Jackson Memorial Hospital, Miami, FL, USA.ORCID 0000-0001-5694-0913
Julie M YabuDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Kailey Hughes KramerTransplant Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA.
Sajal D TannaDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Michael G IsonDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-3347-9671
Robert M RakitaDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Maricar MalinisSection of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-5720-9994
Marwan M AzarSection of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Margaret E McCortRecanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Pooja P SinghDivision of Nephrology, University of New Mexico, Albuquerque, NM, USA.
Arzu VeliogluMarmara University, School of Medicine, Department of Internal Medicine, Division of Nephrology, Istanbul, Turkey.
Sapna A MehtaNYU Langone Transplant Institute, New York, NY, USA.
David van DuinDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0003-4784-3227
Jason D GoldmanDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Erika D LeaseDivision of Pulmonology, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Anna WaldDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Ajit P LimayeDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Cynthia E FisherDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
UW Covid-19 SOT Study Team
University of Miami · USUniversity of Washington · USDuke University · USMassachusetts General Hospital · USIcahn School of Medicine at Mount Sinai · USNorthwestern University · USUniversity of California, Los Angeles · USYale University · USAlbert Einstein College of Medicine · USBaylor College of Medicine · USJohns Hopkins University · USMarmara University · TRNew York University · USThe University of Texas Southwestern Medical Center · USUniversity of New Mexico · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · USUniversity of Pittsburgh · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Training Program in Infectious Diseases in the Immunocompromised HostT32AI118690 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2016 to 2025
$4.0M
Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTGT32AI100851 · NIAID · DUKE UNIVERSITY · PI ALEXANDER, BARBARA D · 2013 to 2022
$1.8M
Respiratory Viral Determinants of Chronic Lung Allograft DysfunctionK23HL143050 · NHLBI · UNIVERSITY OF WASHINGTON · PI FISHER, CYNTHIA E · 2018 to 2022
$986k
NCATS NIH HHS UL1 TR002319NHLBI NIH HHS K23 HL143050NIAID NIH HHS T32 AI100851NIAID NIH HHS T32 AI118690
6 · The paper itself

Abstract

introductionMost studies of solid organ transplant (SOT) recipients with COVID-19 focus on outcomes within one month of illness onset. Delayed mortality in SOT recipients hospitalized for COVID-19 has not been fully examined.

methodsWe used data from a multicenter registry to calculate mortality by 90 days following initial SARS-CoV-2 detection in SOT recipients hospitalized for COVID-19 and developed multivariable Cox proportional-hazards models to compare risk factors for death by days 28 and 90.

resultsVital status at day 90 was available for 936 of 1117 (84%) SOT recipients hospitalized for COVID-19: 190 of 936 (20%) died by 28 days and an additional 56 of 246 deaths (23%) occurred between days 29 and 90. Factors associated with mortality by day 90 included: age > 65 years [aHR 1.8 (1.3-2.4), p =<0.001], lung transplant (vs. non-lung transplant) [aHR 1.5 (1.0-2.3), p=0.05], heart failure [aHR 1.9 (1.2-2.9), p=0.006], chronic lung disease [aHR 2.3 (1.5-3.6), p<0.001] and body mass index ≥ 30 kg/m 2 [aHR 1.5 (1.1-2.0), p=0.02]. These associations were similar for mortality by day 28. Compared to diagnosis during early 2020 (March 1-June 19, 2020), diagnosis during late 2020 (June 20-December 31, 2020) was associated with lower mortality by day 28 [aHR 0.7 (0.5-1.0, p=0.04] but not by day 90 [aHR 0.9 (0.7-1.3), p=0.61].

conclusionsIn SOT recipients hospitalized for COVID-19, >20% of deaths occurred between 28 and 90 days following SARS-CoV-2 diagnosis. Future investigations should consider extending follow-up duration to 90 days for more complete mortality assessment.

Identifiers

PMID35212363
PMCPMC9383518
OpenAlexW4213412879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.